top of page
GBX_EVENTS_2024_womeninscience_#GBX_Staff_#CGTI_#BILS_DDIF_#MEVO
GBX Events Icon

Victor, Lietao Li

Founder & CEO of Zeno Therapeutics

Dr. Li is dedicated to translating "first-in-class" immunotherapies to address critical unmet medical needs through various ventures. Before founding BioIP Holdings (managing Eximmium and Zeno Therapeutics), he co-founded Pika NewBiomed (merged into Yisheng Biopharma, NASDAQ: "LSB") and served as the founding CEO of Lion TCR, SCG Cell Therapy, BioSyngen, and BioCheetah. The founding products of these companies are now advancing at various stages of clinical development, including Phase III, II, and I trial.

Share
  • LinkedIn
  • Youtube
  • X
  • Instagram
How we drive innovation
STORIES
MEETINGS
MEMBERS
Speakers
bottom of page